Biofrontera Inc. (GETTEX:AI10) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Beth J Hoffman | Director · Since at least Nov 2, 2021 |
| Daniel Hakansson | Senior Corporate Counsel · Since at least Nov 5, 2026 |
| Erica Gates | Vice President of Finance · Since at least Oct 28, 2021 |
| Eugene Frederick Leffler | Chief Financial Officer · Since at least Jul 12, 2024 |
| Fred Leffler | Chief Financial Officer · Since at least Aug 13, 2026 |
| George Jones | Chief Commercial Officer · Since at least Aug 11, 2025 |
| Heikki Lanckriet | Board Member · Since at least Jul 3, 2023 |
| Hermann Luebbert | CEO & Chairman · Since at least Jul 22, 2025 |
| John J. Borer | Board Member · Since at least Nov 4, 2026 |
| John J Borer III | Director · Since at least Nov 2, 2021 |
| Jon Lyons | Vice President of Scientific & Medical Affairs · Since at least Nov 4, 2026 |
| Kevin D. Weber | Board Member · Since at least Mar 2, 2022 |
| Samantha Widdicombe | Senior Vice President of Sales & Strategic Accounts · Since at least Nov 5, 2026 |
| Wiebke Meyer-Wendt | Vice President of Global Quality & Research · Since at least Nov 5, 2026 |